Showing 291-300 of 334 grants

Title Institution Researcher Program Duration Total Award Amount
In vivo analysis of human islet graft infiltration and its immunomodulation by antigen-specific therapy Trustees of Columbia University in the City of New York Remi Creusot Cures 01-August-2022 to 31-July-2025 $699.997,82
Innovating Methods for AssessinG INsulin Action in Type ONe diabetes (IMAGINATiON) Regents of the University of Colorado Kristen Nadeau Improving Lives 01-December-2021 to 30-November-2025 $445.816,29
EFFICACY AND SAFETY OF ONCE WEEKLY SEMAGLUTIDE IN ADULTS WITH OBESITY AND INADEQUATELY CONTROLLED TYPE 1 DIABETES USING HYBRID CLOSED-LOOP SYSTEM Regents of the University of Colorado Janet Snell-Bergeon Improving Lives 01-November-2022 to 31-October-2026 $2.282.771,83
Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes Regents of the University of Colorado Jessica Kendrick Improving Lives 01-October-2022 to 30-September-2026 $899.235,00
Understanding the role of scaffold microarchitecture on survival and function of stem cell-derived beta cells Brown University Tejal Desai Cures 01-October-2022 to 30-September-2025 $474.761,58
Avera eCare School Health T1D Demonstration Project Avera McKennan Christine Hockett Improving Lives 01-November-2021 to 31-July-2025 $4.000.979,73
Ultrafast Insulin-Pramlintide Co-formulations Stanford University Eric Appel Improving Lives 01-September-2022 to 31-August-2025 $795.000,00
Local delivery of beta-cell survival factors and immunomodulators to enable highly efficient immunosuppression-free islet transplantation Brown University Tejal Desai Cures 01-October-2022 to 01-October-2025 $714.857,80
Optimization of fast-acting venom insulins as therapeutic candidates for T1D University of Utah Helena Safavi Improving Lives 01-September-2022 to 31-August-2026 $890.372,53
Deep Learning-based Analyses of Pancreatic Islet Beta-Cell Heterogeneity and MRI Pancreas Volume as Biomarkers to Improve Understanding of Type 1 Diabetes Progression University of Florida Sarah Kim Cures 01-June-2022 to 31-May-2026 $750.000,00